Alzheimer’s Drug Shrinks Brain Volume by Removing Amyloid Plaques
Summary: Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques ...
Summary: Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques ...
Summary: Two widespread compounds, inexperienced tea catechins and resveratrol, a compound present in purple wine, cut back the formation of ...